Mindset Pharma IncCSE: MSET

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

· Issued by Mindset Pharma Inc

(NewsDirect)

Mindset Pharma CEO James Lanthier joins Proactive's Natalie Stoberman to discuss the company's latest update to expand into non-hallucinogenic therapeutic drug discovery.

Lanthier says Mindset has been one of the first biotech companies in the psychedelic space to apply state-of-the-art medicinal chemistry and behavioural pharmacology techniques to novel scaffolds of psychedelic drugs with the goal of discovering new medicines.

He adds that the company has been working towards discovering novel psychedelic-inspired non-hallucinogenic drug candidates and has found multiple candidates with a promising preclinical profile.

Watch the video on YouTube

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Mindset Pharma Inc on 6ix

Earlier from Mindset Pharma

Later from Mindset Pharma

All Mindset Pharma news releases